Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Eli Lilly and Nvidia are building a GPU-powered AI supercomputer to speed up drug discovery, launching in January 2026.
Eli Lilly and Nvidia have partnered to build a supercomputer powered by over 1,000 Nvidia Blackwell Ultra GPUs, launching in January 2026 to accelerate drug discovery and development.
The AI-driven system, operated by Lilly, will enable millions of virtual experiments simultaneously, drastically cutting the time and cost of bringing new treatments to market.
It will serve as an "artificial intelligence factory," supporting research across drug discovery, manufacturing, medical imaging, and personalized medicine.
The initiative expands Lilly’s open-access Lilly TuneLab platform, allowing biotech firms to access proprietary AI models without sharing sensitive data.
The project is part of Lilly’s $50 billion U.S. R&D investment and is expected to create thousands of high-wage jobs.
Eli Lilly y Nvidia están construyendo una supercomputadora de IA con GPU para acelerar el descubrimiento de medicamentos, lanzada en enero de 2026.